Cargando…

Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis

BACKGROUND: The advent of IMRT and image-guided radiotherapy (IGRT) in combination with involved-field radiotherapy (IF-RT) in inoperable non-small-cell lung cancer results in a decreased incidental dose deposition in elective nodal stations. While incidental nodal irradiation is considered a releva...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleckenstein, Jochen, Eschler, Andrea, Kremp, Katharina, Kremp, Stephanie, Rübe, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554351/
https://www.ncbi.nlm.nih.gov/pubmed/26292716
http://dx.doi.org/10.1186/s13014-015-0485-6
_version_ 1782388042457153536
author Fleckenstein, Jochen
Eschler, Andrea
Kremp, Katharina
Kremp, Stephanie
Rübe, Christian
author_facet Fleckenstein, Jochen
Eschler, Andrea
Kremp, Katharina
Kremp, Stephanie
Rübe, Christian
author_sort Fleckenstein, Jochen
collection PubMed
description BACKGROUND: The advent of IMRT and image-guided radiotherapy (IGRT) in combination with involved-field radiotherapy (IF-RT) in inoperable non-small-cell lung cancer results in a decreased incidental dose deposition in elective nodal stations. While incidental nodal irradiation is considered a relevant by-product of 3D-CRT to control microscopic disease this planning study analyzed the impact of IMRT on dosimetric parameters and tumor control probabilities (TCP) in elective nodal stations in direct comparison with 3D-CRT. METHODS AND MATERIALS: The retrospective planning study was performed on 41 patients with NSCLC (stages II-III). The CTV was defined as the primary tumor (GTV + 3 mm) and all FDG-PET-positive lymph node stations. As to the PTV (CTV + 7 mm), both an IMRT plan and a 3D-CRT plan were established. Plans were escalated until the pre-defined dose-constraints of normal tissues (spinal cord, lung, esophagus and heart) were reached. Additionally, IMRT plans were normalized to the total dose of the corresponding 3D-CRT. For two groups of out-of-field mediastinal node stations (all lymph node stations not included in the CTV (LN(all_el)) and those directly adjacent to the CTV (LN(adj_el))) the equivalent uniform dose (EUD) and the TCP (for microscopic disease a D50 of 36.5 Gy was assumed) for the treatment with IMRT vs 3D-CRT were calculated. RESULTS: In comparison, a significantly higher total dose for the PTV could be achieved with the IMRT planning as opposed to conventional 3D-CRT planning (74.3 Gy vs 70.1 Gy; p = 0.03). In identical total reference doses, the EUD of LN(adj_el) is significantly lower with IMRT than with 3D-CRT (40.4 Gy vs. 44.2 Gy. P = 0.05) and a significant reduction of TCP with IMRT vs 3D-CRT was demonstrated for LN(all_el) and LN(adj_el) (12.6 % vs. 14.8 %; and 23.6 % vs 27.3 %, respectively). CONCLUSIONS: In comparison with 3D-CRT, IMRT comes along with a decreased EUD in out-of-field lymph node stations. This translates into a statistically significant decrease in TCP-values. Yet, the combination of IF-RT and IMRT leads to a significantly better sparing of normal tissues and higher total doses whereas the potential therapeutic drawback of decreased incidental irradiation of elective lymph nodes is moderate.
format Online
Article
Text
id pubmed-4554351
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45543512015-09-01 Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis Fleckenstein, Jochen Eschler, Andrea Kremp, Katharina Kremp, Stephanie Rübe, Christian Radiat Oncol Research BACKGROUND: The advent of IMRT and image-guided radiotherapy (IGRT) in combination with involved-field radiotherapy (IF-RT) in inoperable non-small-cell lung cancer results in a decreased incidental dose deposition in elective nodal stations. While incidental nodal irradiation is considered a relevant by-product of 3D-CRT to control microscopic disease this planning study analyzed the impact of IMRT on dosimetric parameters and tumor control probabilities (TCP) in elective nodal stations in direct comparison with 3D-CRT. METHODS AND MATERIALS: The retrospective planning study was performed on 41 patients with NSCLC (stages II-III). The CTV was defined as the primary tumor (GTV + 3 mm) and all FDG-PET-positive lymph node stations. As to the PTV (CTV + 7 mm), both an IMRT plan and a 3D-CRT plan were established. Plans were escalated until the pre-defined dose-constraints of normal tissues (spinal cord, lung, esophagus and heart) were reached. Additionally, IMRT plans were normalized to the total dose of the corresponding 3D-CRT. For two groups of out-of-field mediastinal node stations (all lymph node stations not included in the CTV (LN(all_el)) and those directly adjacent to the CTV (LN(adj_el))) the equivalent uniform dose (EUD) and the TCP (for microscopic disease a D50 of 36.5 Gy was assumed) for the treatment with IMRT vs 3D-CRT were calculated. RESULTS: In comparison, a significantly higher total dose for the PTV could be achieved with the IMRT planning as opposed to conventional 3D-CRT planning (74.3 Gy vs 70.1 Gy; p = 0.03). In identical total reference doses, the EUD of LN(adj_el) is significantly lower with IMRT than with 3D-CRT (40.4 Gy vs. 44.2 Gy. P = 0.05) and a significant reduction of TCP with IMRT vs 3D-CRT was demonstrated for LN(all_el) and LN(adj_el) (12.6 % vs. 14.8 %; and 23.6 % vs 27.3 %, respectively). CONCLUSIONS: In comparison with 3D-CRT, IMRT comes along with a decreased EUD in out-of-field lymph node stations. This translates into a statistically significant decrease in TCP-values. Yet, the combination of IF-RT and IMRT leads to a significantly better sparing of normal tissues and higher total doses whereas the potential therapeutic drawback of decreased incidental irradiation of elective lymph nodes is moderate. BioMed Central 2015-08-21 /pmc/articles/PMC4554351/ /pubmed/26292716 http://dx.doi.org/10.1186/s13014-015-0485-6 Text en © Fleckenstein et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Fleckenstein, Jochen
Eschler, Andrea
Kremp, Katharina
Kremp, Stephanie
Rübe, Christian
Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
title Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
title_full Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
title_fullStr Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
title_full_unstemmed Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
title_short Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis
title_sort dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (imrt) vs 3d-conformal radiotherapy (3d-crt) of non-small-cell lung cancer: an in silico analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554351/
https://www.ncbi.nlm.nih.gov/pubmed/26292716
http://dx.doi.org/10.1186/s13014-015-0485-6
work_keys_str_mv AT fleckensteinjochen dosedistributionandtumorcontrolprobabilityinoutoffieldlymphnodestationsinintensitymodulatedradiotherapyimrtvs3dconformalradiotherapy3dcrtofnonsmallcelllungcanceraninsilicoanalysis
AT eschlerandrea dosedistributionandtumorcontrolprobabilityinoutoffieldlymphnodestationsinintensitymodulatedradiotherapyimrtvs3dconformalradiotherapy3dcrtofnonsmallcelllungcanceraninsilicoanalysis
AT krempkatharina dosedistributionandtumorcontrolprobabilityinoutoffieldlymphnodestationsinintensitymodulatedradiotherapyimrtvs3dconformalradiotherapy3dcrtofnonsmallcelllungcanceraninsilicoanalysis
AT krempstephanie dosedistributionandtumorcontrolprobabilityinoutoffieldlymphnodestationsinintensitymodulatedradiotherapyimrtvs3dconformalradiotherapy3dcrtofnonsmallcelllungcanceraninsilicoanalysis
AT rubechristian dosedistributionandtumorcontrolprobabilityinoutoffieldlymphnodestationsinintensitymodulatedradiotherapyimrtvs3dconformalradiotherapy3dcrtofnonsmallcelllungcanceraninsilicoanalysis